Results 61 to 70 of about 4,320,983 (278)
The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop. [PDF]
, 2012 BACKGROUND: The txt2stop trial has shown that mobile-phone-based smoking cessation support doubles biochemically validated quitting at 6 months. This study examines the cost-effectiveness of smoking cessation support delivered by mobile phone text ...
Cairns, John +5 more
core +2 more sources
Decision Analysis and Cost-Effectiveness Analysis [PDF]
Seminars in Spine Surgery, 2009 Healthcare decision-making can be complex, often requiring decision makers to weigh serious trade-offs, consider patients' values, and incorporate evidence in the face of uncertainty. Medical decisions are made implicitly by clinicians and other decision-makers on a daily basis. Decisions based largely on personal experience are subject to many biases.
Jon D. Lurie +4 more
openaire +3 more sources
British medical journal, 2017 Objectives To evaluate the impact of total knee replacement on quality of life in people with knee osteoarthritis and to estimate associated differences in lifetime costs and quality adjusted life years (QALYs) according to use by level of symptoms ...
B. Ferket +5 more
semanticscholar +1 more source
Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis.
Health Technology Assessment, 2017 BACKGROUND Atrial fibrillation (AF) is a common cardiac arrhythmia that increases the risk of thromboembolic events. Anticoagulation therapy to prevent AF-related stroke has been shown to be cost-effective.
N. Welton +15 more
semanticscholar +1 more source
Cost-effectiveness of [18F] fluoroethyl-L-tyrosine for temozolomide therapy assessment in patients with glioblastoma [PDF]
, 2019 Background and Purpose: Glioblastomas are the most aggressive of all gliomas. The prognosis of these gliomas, which are classified as grade IV tumors by the World Health Organization (WHO), is poor.
Baguet, Tristan +3 more
core +1 more source
Cost–Effectiveness Analysis in Pharmacogenomics [PDF]
Pharmacogenomics, 2010 The existence of finite healthcare budgets drives the need to consider opportunity cost and demonstrate that pharmacogenomic interventions offer added value, in terms of the relative costs and benefits, compared with current practice. This is where the framework of cost-effectiveness analysis is useful.
Katherine Payne, FH Shabaruddin
openaire +3 more sources
ClinicoEconomics and Outcomes Research, 2010 Rashid Kazerooni1, Mark Bounthavong1,21Pharmacoeconomics/Formulary Management, Veterans Affairs San Diego Healthcare System, San Diego, CA, USA; 2UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences, San Diego, CA, USAObjective: There has been ...
Rashid Kazerooni, Mark Bounthavong
doaj
Offering the Choice of Self-Administered Oral HIV Testing (CHIVST) among Long-distance Truck Drivers in Kenya: A Trial-based Cost-effectiveness Analysis [PDF]
, 2020 Background: Long distance truck drivers (LDTD) are a high-HIV-risk population facing unique healthcare barriers due to continuous travel and irregular schedules, and may require targeted, resource-intensive strategies for HIV-test uptake.
Kimmel, April D., Mujwara, Deo
core +1 more source
Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial
PharmacoEconomics (Auckland), 2016 Health policy instruments such as the public financing of health technologies (e.g., new drugs, vaccines) entail consequences in multiple domains. Fundamentally, public health policies aim at increasing the uptake of effective and efficient interventions
S. Verguet, Jane J. Kim, D. Jamison
semanticscholar +1 more source
Optimising the management of vaginal discharge syndrome in Bulgaria: cost effectiveness of four clinical algorithms with risk assessment [PDF]
, 2010 OBJECTIVES: To evaluate the performance and cost effectiveness of the WHO recommendations of incorporating risk-assessment scores and population prevalence of Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) into vaginal discharge syndrome (VDS)
Anguenot, J-L +10 more
core +4 more sources